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INTRODUCTION: Helicobacter pylori is one of the main
causes of gastroduodenal diseases, such as chronic
gastritis and peptic ulcer. It has been shown that
eosinophils increase in the stomach in H. pylori
infection. Eosinophilic cationic protein (ECP) is a
cytotoxic molecule secreted by the activated eosino-
phils. However, there are no sufficient data about the
role of ECP in H. pylori infection and its effect on
ulcer development. In this study we investigated the
gastric eosinophilic infiltration, gastric juice and
serum ECP levels in patients with chronic gastritis
and gastric ulcer associated with H. pylori.
Materials and methods: Forty-four H. pylori-positive
and 20 H. pylori-negative patients who underwent
upper gastrointestinal system endoscopy after admit-
ting with dyspeptic complaints were enrolled in the
study. Twenty-one of the H. Pylori-positive patients
had gastric ulcer while 23 patients had none. During
endoscopy, multiple gastric biopsies and juices were
taken. In gastric biopsies, H. pylori and eosinophilic
infiltration were assessed. Additionally, gastric juice
and serum ECP levels were measured.
Results: Eosinophil infiltration, gastric juice ECP
levels, and gastric juice/serum ECP ratios in the H.
pylori-positive group were greater than in the
H. pylori-negative group (p B /0.01). There was no
statistically significant difference regarding serum
ECP levels between the two groups (p   /0.05). When
H. pylori-positive patients were compared with re-
gard to gastric ulcer presence, however, there was no
significant difference in gastric eosinophil infiltra-
tion, gastric juice ECP levels, serum ECP levels, and
gastric juice/serum ECP ratios (p   /0.05).
Conclusion: The results of this study suggest that
eosinophils and eosinophil-released ECP may con-
tribute to inflammatory changes seen in chronic
gastritis, whereas there is no proof that they play a
role in ulcer development.
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Introduction
Helicobacter pylori is one of the main causes of
gastroduodenal diseases, such as chronic gastritis and
peptic ulcer. In addition, it is closely associated with
gastric carcinoma and gastric B-cell mucosa-asso-
ciated lymphoid tissue lyphoma.
14 H. pylori causes
chronic gastritis in all patients whereas only a small
proportion of patients infected with this microorgan-
ism develop a peptic ulcer.
5 Inflammatory response is
pivotal in the epithelial dysfunction and mucosal
injury caused by H. pylori. H. pylori leads to mucosal
increases in many proinflammatory and immunore-
gulatory cytokines.
68
Eosinophils are involved in a broad range of
diseases such as allergic, inflammatory, and malig-
nant disorders.
911 Several recent studies focused on
the function of eosinophils in gastrointestinal dis-
ease.
10,12,13 They are present only in small amounts in
healthy gut mucosa.
14,15 Their presence has been
considered to be a protective mechanism against
bacteria and parasites.
11 The specific granules of the
eosinophils contain a number of highly cationic
proteins.
16,17 One of the very important of these is
the eosinophil cationic protein (ECP). They are
markedly cationic proteins with cytotoxic capacities
probably leading to tissue destruction as well as
modulators of the immune response.
18,19 There is
increasing evidence that eosinophils are functionally
involved in the pathophysiology of various inflam-
matory disorders of the gut.
12,20
It has been showed that eosinophils increase in
the stomach in H. pylori infection.
2123 However,
there are not sufficient studies about the role of ECP
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369in H. pylori infection and its effect on ulcer develop-
ment. We investigated in this study gastric eosinophil
infiltration, gastric juice and serum ECP levels in
patients with chronic gastritis and gastric ulcer
associated with H. pylori.
Research design and methods
Patients
In total, 44 H. pylori-positive patients above the age of
20 years who underwent endoscopy in the gastro-
enterology laboratory because of dyspeptic com-
plaints (group 1) were enrolled into the study. The
patients were divided into two subgroups according
to the presence of a gastric ulcer (group 1a, ulcer
present; group 1b, ulcer absent). As the control group
we selected 20 H. pylori-negative patients admitted
with dyspeptic complaints who were gastric ulcer
negative (group 2). Exlusion criteria were prior
eradication therapy for H. pylori, anti-ulcer drug use
within the past 1 month, gastrointestinal system and
other organ malignancies, inflamatuar and infectious
diseases, and prior gastric surgery.
Endoscopic procedure
Gastroduodenal endoscopic examination was per-
formed following overnight fasting using a Pentax
EG2930K (Asahi Optical, Tokyo, Japan). In each
patient, 5 cm
3 of gastric juice, obtained during
endoscopy through a sterilised tube fitted in the
operation channel of the gastroscope, were collected.
For the histopathological examination, multiple biop-
sies from the antrum and the corpus were taken. The
biopsy samples were sent to the pathology laboratory
for examination in 10% buffered formalin.
Assessment of the state of H. pylori infection
The state of H. pylori infection was assessed histolo-
gically. The biopsy specimens were fixed in 10%
formalin and embedded in paraffin. The precense of
H. pylori was determined by Giemsa staining as the
presence of typical gently spiralled or curved bac-
teria. When at least one of the biopsies of each
patient yielded a positive result, the patient was
considered positive for H. pylori.
Histological assesment eosinophil infiltration
Sections were also stained with hematoxylin and
eosin. For each section, five superficial fields ( /400
magnification) were randomly selected; eosinophils
were individually counted by the same investigator
and a mean score between five fields was obtained
from each patient.
21 The hematoxylin and eosin-
stained specimen was given one overall score from 0
to 3 for eosinphil infiltration (0 /no eosinophil
infiltration, 1 /mild or patchhy eosinphil infiltration,
2 /moderate eosinphil infiltration, 3 /marked, con-
fluent eosinphil infiltration).
Serum and gastric juice ECP measurement
Serawereobtainedinafastingstatebeforeendoscopy.
Serum and gastric juice ECP levels were measured
with a fluoroenzymeimmunoassay kit and a UNICAP
device (Pharmacia&Upjohn, Uppsala, Sweden).
Statistical analysis
Results are expressed as the mean9 /standard devia-
tion. In the comparison between groups, statistically
significant differences were assessed by the Student
t-test and the Mann/Whitney U-test. P B /0.05 was
considered statistically significant.
Results
When the patients were divided into two groups
according to H. pylori presence, group 1 had a total
of 44 patients (25 males and 19 females). The mean
age of the patients was 43.29 /11.3 years. Group 2
included a total of 20 patients (11 males and nine
females). In this group the mean age was 42.59 /10.1
years. The age and sex distribution had an insignif-
icant difference in both groups (p  /0.05). Demo-
graphic characteristics, mean eosinophil scores,
gastric juice ECP levels, serum ECP levels, and gastric
juice/serum ECP ratios for both groups are presented
in Table 1. Eosinophil scores, gastric juice ECP levels,
and gastric juice/serum ECP ratios were apparently
greater in group 1 than group 2 (pB /0.01). Serum
ECP levels were higher in the H. pylori-positive
group than the H. pylori-negative group, although a
statistically significant difference was not present
(p  /0.05).
The age, sex, mean eosinophil scores, gastric juice
ECP levels, serum ECP levels, gastric juice/serum
ECP ratios of group 1a and group 1b are presented in
Table 2. Both the age and sex distribution had
an insignificant difference between the two groups
(p  /0.05). There was no significant difference in
gastric eosinophil scores, gastric juice ECP levels,
serum ECP levels, and gastric/serum ECP ratios
between group 1a and group 1b (p  /0.05).
In a comparison of group 1a and group 1b with
group 2, gastric eosinophil scores, gastric juice ECP
levels, gastric juice/serum ECP ratios were greater in
both group 1 subgroups than in group 2 (pB /0.01).
There was no significant difference between groups
according to the serum ECP levels (p  /0.05).
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H. pylori is the most common bacterial infection
worldwide. It is estimated that 60% of the world’s
population is infected by this microorganism.
H. pylori is generally acquired in childhood and
causes lifelong chronic gastritis unless initial acute
gastritis is adequately managed.
24,25 Approximately
20% of persons infected by H. pylori develop peptic
ulcer disease in some period of their lifespan.
5 Antral
biopsies of individuals infected with H. pylori show
focal epithelial cell damage as well as an inflamma-
tory infiltrate in the lamina propria. This infiltrate
consists of polymorphonuclear leukocytes, eosino-
phils, and mononuclear cells.
7,2429 Inflammatory
response is pivotal in the epithelial dysfunction and
mucosal injury caused by H. pylori. H. pylori
stimulates the release of a variety of inflammatory
mediators both directly by bacterial products such as
vacuolating cytotoxin, lipopolysaccharide, neutro-
phil-activating factor and porins, and indirectly as a
result of interaction with gastric epithelial cells.
6,8,28,30
The role of eosinophils in the pathogenesis of H.
pylori-associated gastritis and ulcer is not clearly
explained.
The present study provides some evidence of an
association between gastric eosinophil infiltration,
gastric juice ECP and serum ECP levels in H. pylori
infection and gastric ulcer disease.
Eosinophils play a role in many disorders, such as
allergic, immunologic, and malignant diseases.
911
Eosinophil granulocytes, predominantly tissue-dwell-
ing cells, are normally present in low numbers in
healthy gut mucosa.
14,15 A possible role of the
eosinophil in several intestinal diseases has been
suggested. Patients with celiac disease have been
shown to have prominent infiltration of eosinophils
in the lamina propria, and activation of eosinophils
was suggested by the release of ECP in the tissue and
lumen of the intestine.
31 The eosinophil may also be
a major actor in the pathogenesis of inflammatory
bowel disease because bowel biopsies from patients
with inflammatory bowel disease have demonstrated
an infiltration of eosinophils in the lamina propria
and marked extracellular deposits of ECP.
10,14,18,32
Moreover, eosinophilic gastrointestinal tract infiltra-
tion is encountered in food allergies and eosinophilic
gastroenteritis.
12,14,15
The presence of eosinophils is assumed as a
protective mechanism of unspecific mucosal immu-
nity response against bacteria and parasites.
11,15 Since
eosinophil granules contain many proinflammatory
and cytotoxic mediators, their protective role has
become controversial.
14 Activation of eosinophils
seems to contribute to the pathophysiology of several
inflammatory conditions.
18,19,32 The role of the eosi-
nophil granulocyte in the inflammatory reaction still
remains obscure. One of the major constituents of the
granule matrix is the eosinophil cationic protein. It is
not only a strong helminthotoxic mediator, but it can
also turn its destructive mechanisms against the host
by cytotoxicity toward a variety of target cells
including epithelial cells, smooth muscle cells, and
nerve cells.
10,14,17
We found that gastric mucosal eosinophil infiltra-
tion and the gastric juice ECP level were apparently
greater in H. pylori-infected subjects. According to
Table 1. Demographic characteristics, mean eosinophil score, gastric juice ECP level, serum ECP level and gastric juice/serum
ECP ratio in H. pylori presence
Parameter Group 1 Group 2 p value
Subjects (n)4 4 2 0
Mean age (years) 43.29 /11.3 (20/60) 42.59 /10.1 (22/54) Not significant
Sex (male/female) 25/19 11/9 Not significant
Eosinophil score 1.149 /0.95 0.359 /0.59 B /0.01
Gastric juice ECP (mg/l) 54.89 /51.6 19.19 /18.6 B /0.01
Serum ECP (mg/l) 19.79 /20.1 14.19 /8.1 Not significant
Gastric juice/serum ECP ratio 4.249 /4.06 1.249 /1.01 B /0.01
Group 1 /H. pylori positive, Group 2 /H. pylori negative.
Table 2. Demographic characteristics, mean eosinophil scores, gastric juice ECP level, serum ECP level and gastric juice/
serum ECP ratio in H. pylori-positive patients according to the presence or absence of gastric ulcer
Parameter Group 1a Group 1b p value
Subjects (n)2 1 2 3
Mean age (years) 41.19 /10.7 (20/60) 45.29 /11.7 (29/59) Not significant
Sex (male/female) 12/9 13/10 Not significant
Eosinophil score 1.299 /0.85 1.029 /1.4 Not significant
Gastric juice ECP (mg/l) 56.519 /47.1 53.39 /56.6 Not significant
Serum ECP (mg/l) 20.59 /19.3 19.19 /21.1 Not significant
Gastric juice/serum ECP ratio 4.649 /4.54 3.889 /3.63 Not significant
Group 1a /H. pylori positive, gastric ulcer present.
Group 1b /H. pylori positive, gastric ulcer absent.
Helicobacter pylori-associated chronic gastritis and gastric ulcer
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ence between two groups was found. On the other
hand, gastric juice/serum ECP ratios were greater in
patients infected by H. pylori. We failed to find any
significant difference in regard to gastric mucosal
eosinophil infiltration, gastric juice ECP levels, serum
ECP levels and gastric juice/serum ECP ratios be-
tween those patients having gastric ulcer disease and
those having not.
There are inadequate data in the literature on the
role of eosinophil-associated ECP on diseases caused
by H. pylori. In a study by McGovern et al.,
21
eosinophilic infiltration and degranulation in gastric
mucosa were investigated histopathologically in
H. pylori infection, and eosinophilic infiltration and
degranulation in gastric mucosa were greater in
patients with H. pylori gastritis. Berstad et al.
33 in
their study revealed that gastric juice ECP concentra-
tion was apparently greater in H. pylori-positive
patients than the negative ones. We also found in
accordance with the aforementioned studies that
eosinophil infiltration in gastric mucosa and gastric
juice ECP levels increased in H. pylori-positive
patients. Ojetti et al.
34 assessed serum/gastric juice
ECP levels and gastric mucosal eosinophil infiltration
in idiopathic chronic urticaria patients infected or not
with H. pylori and evaluated the modification after
bacterium eradication. However, they found that
H. pylori infection affects gastric juice ECP and
eosinophil infiltration of only idiopathic chronic
urticaria patients.
As a result, it has been demonstrated that eosino-
phil infiltration in gastric mucosa and ECP levels in
the gastric juice are increased in H. pylori-positive
patients whereas serum ECP levels do not change
significantly. No apparent difference was found in
eosinophilic infiltration in gastric mucosa, gastric
juice and serum ECP levels between patients with
and without gastric ulcer. This result, although it
supports the role of eosinophils and eosinophil-
derived ECP in inflammatory changes in chronic
gastritis, suggests that these two factors do not
contribute to gastric ulcer disease development.
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